Stockreport

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

Traws Pharma, Inc.  (TRAW) 
PDF Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk of long COVID due to a lo [Read more]